Academic-industrial collaboration in the development of the first angiotensin receptor blocker: neprilysin inhibitor in the treatment of heart failure

European Heart Journal

15 February 2016

Organised by:

Author

Brigham and Women's Hospital, Harvard Medical School Boston , United States of America